ArticleVirology journal2026
Single-cell characterization of the CD8
Article in Virology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Although antiretroviral therapy (ART) effectively suppresses HIV-1 viremia, immune dysfunction often persists. Here, we integrated single-cell RNA and T cell receptor (TCR) sequencing data to delineate the alterations of CD8⁺ T cells. Based on cross-sectional samples from different individuals (healthy donors, treatment-naïve individuals, and ART-treated individuals), we found ART promoted the transition of CD8⁺ T cells from exhausted toward naïve and memory-like subsets. Weighted gene co-expression network analysis identified distinct modules, including three (SM2-SM4) highly expressed in treatment-naïve individuals and one (SM6) significantly elevated post-ART. The reduced TCR diversity and increased clonality observed post-infection were not fully restored by ART, although ART partly altered clonal structure and CDR3 length. We established a predictive model based on the TCR features of CD8⁺ T cells, which accurately distinguished healthy donors, treatment-naïve individuals, and ART-treated individuals. These findings clarify the complex landscape of CD8⁺ T cell reconstitution, and identify key transcriptional networks and clonal dynamics during ART.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.